Sign in

CIK 0001439222

  • Large accelerated filer

AGIOS PHARMACEUTICALS, INC.

Sign in to watch
Ticker
AGIO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 617-649-8600
Business address
88 SIDNEY STREET, CAMBRIDGE, MA, 02139
Former names
AGIOS PHARMACEUTICALS INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$371,112
in 2 filings, $371K under 10b5-1 plans

Net −$371,112. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Gheuens Sarah −$371K Chief Medical Officer sold 15% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2015-06-01 Bowden Christopher Chief Medical Officer Exercise or conversion · Stock option (right to buy) −5,000 132,000
2015-05-29 NELSEN ROBERT Director Other disposition −300,000 2,402,516
2015-05-29 NELSEN ROBERT Director Other acquisition +1,733 8,422
2015-05-27 Schenkein David P Chief Executive Officer Sale −8,929 $120.05 $1.1M 85,582
2015-05-27 Goddard Glenn Senior Vice President, Finance Exercise or conversion +2,171 $23.10 $50K 2,171
2015-05-27 Goddard Glenn Senior Vice President, Finance Sale −2,171 $120.05 $261K 0
2015-05-27 Goddard Glenn Senior Vice President, Finance Exercise or conversion · Stock option (right to buy) −2,171 109,098
2015-05-20 Cantley Lewis Clayton Jr. Director Sale −2,426 $116.60 $283K 167,262
2015-05-20 Cantley Lewis Clayton Jr. Director Sale −2,426 $116.60 $283K 167,262
2015-05-19 Cantley Lewis Clayton Jr. Director Sale −2,426 $116.69 $283K 169,688
2015-05-19 Cantley Lewis Clayton Jr. Director Sale −2,426 $116.66 $283K 169,688
2015-05-15 Higgons John Duncan Chief Operating Officer Sale −7,417 $112.89 $837K 98,835
2015-05-12 Schenkein David P Chief Executive Officer Sale −2,093 $110.03 $230K 94,701
2015-05-11 Schenkein David P Chief Executive Officer Sale −3,107 $110.01 $342K 96,794
2015-05-11 NELSEN ROBERT Director Other disposition −386,074 2,702,516
2015-05-11 NELSEN ROBERT Director Other acquisition +2,229 6,689
2015-05-08 Schenkein David P Chief Executive Officer Sale −2,600 $101.32 $263K 238,772
2015-05-08 Schenkein David P Chief Executive Officer Sale −1,300 $101.32 $132K 99,901
2015-05-07 Biller Scott Chief Scientific Officer Sale −5,500 $96.32 $530K 34,070
2015-05-07 Schenkein David P Chief Executive Officer Exercise or conversion +10,000 $0.30 $3K 241,372

Page 91 of 93 · 1,853 trades